Avera Pharmaceutical

Specialty pharmaceutical company that acquires, develops, and commercializes pharmaceutical compounds.

Launch date

2002

Market cap

Enterprise valuation

San Diego California (HQ)

Date	Investors	Amount	Round
Apr 2002	InterWest Partners Bay City Capital Frazier Healthcare Partners	$20.0m	Series A
Dec 2003	InterWest Partners Bay City Capital Frazier Healthcare Partners	$8.0m	Series B
Aug 2004	BTG InterWest Partners Bay City Capital Montreux Equity Partners Aberdare Ventures HIG Capital Frazier Healthcare Partners St. Paul Venture Capital Windamere Venture Partners Perseus-Soros Biopharmaceutical Fund	$48.0m	Series C
Total Funding		AUD117m

Recent News about Avera Pharmaceutical